MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.560 -0.030 (-1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
Via CannabisNewsWire
Topics Intellectual Property
News headline image
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
Via Investor Brand Network
Topics Intellectual Property
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
News headline image
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
Via CannabisNewsWire
Topics Intellectual Property
News headline image
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
News headline image
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller
Via Investor Brand Network
News headline image
InMed Provides Update on Management Changes
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease
InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a pharmaceutical research and development company that is focused on utilizing cannabinoids and related 
Via Spotlight Growth
News headline image
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
S&P 500 Down 0.8%; Lowe's Earnings Top Expectations ↗
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 1.5% on Wednesday. 
Via Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor
Via Investor Brand Network
News headline image
Dow Edges Higher; Crude Oil Drops Sharply ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Wednesday. 
Via Benzinga
News headline image
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
Nasdaq Drops Over 100 Points; US Retail Sales Rise 1.3% ↗
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Wednesday. 
Via Benzinga
News headline image
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a look at the biggest pre-market stock movers that traders will want to know about for Tuesday morning! 
Via InvestorPlace
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update
Via Investor Brand Network
News headline image
Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday ↗
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event
Via Investor Brand Network
News headline image
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022
Meet with InMed’s President and CEO Eric A. Adams and Eric Hsu, SVP of Preclinical Research and Development 
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
News headline image
InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story